Literature DB >> 28109950

Coumarin derivatives as potential antitumor agents: Growth inhibition, apoptosis induction and multidrug resistance reverting activity.

Alessandra Bisi1, Concettina Cappadone2, Angela Rampa3, Giovanna Farruggia4, Azzurra Sargenti5, Federica Belluti3, Rita M C Di Martino3, Emil Malucelli5, Alessia Meluzzi5, Stefano Iotti4, Silvia Gobbi3.   

Abstract

A small library of coumarins, carrying butynyl-amino chains, was synthesized continuing our studies in the field of MDR reverting ageEnts and in order to obtain multipotent agents to combat malignancies. In particular, the reported anticancer and chemopreventive natural product 7-isopentenyloxycoumarin was linked to different terminal amines, selected on the basis of our previously reported results. The anticancer behaviour and the MDR reverting ability of the new compounds were evaluated on human colon cancer cells, particularly prone to develop the MDR phenotype. Some of the new derivatives showed promising effects, directly acting as cytotoxic compounds and/or counteracting MDR phenomenon. Compound 1e emerged as the most interesting of this series, showing a multipotent biological profile and suggesting that conjugation of an appropriate coumarin core with a properly selected butynyl-amino chain allows to obtain novel hybrid molecules endowed with improved in vitro antitumor activity.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anticancer; Chemosensitizers; Coumarin; MDR modulators; P-glycoprotein

Mesh:

Substances:

Year:  2017        PMID: 28109950     DOI: 10.1016/j.ejmech.2017.01.020

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  6 in total

Review 1.  The Effects of Synthetically Modified Natural Compounds on ABC Transporters.

Authors:  Daniel Dantzic; Pawan Noel; Fabrice Merien; Dong-Xu Liu; Jun Lu; Haiyong Han; Mark J McKeage; Yan Li
Journal:  Pharmaceutics       Date:  2018-08-09       Impact factor: 6.321

2.  Promising New Inhibitors of Tyrosyl-DNA Phosphodiesterase I (Tdp 1) Combining 4-Arylcoumarin and Monoterpenoid Moieties as Components of Complex Antitumor Therapy.

Authors:  Tatyana M Khomenko; Alexandra L Zakharenko; Arina A Chepanova; Ekaterina S Ilina; Olga D Zakharova; Vasily I Kaledin; Valeriy P Nikolin; Nelly A Popova; Dina V Korchagina; Jóhannes Reynisson; Raina Chand; Daniel M Ayine-Tora; Jinal Patel; Ivanhoe K H Leung; Konstantin P Volcho; Nariman F Salakhutdinov; Olga I Lavrik
Journal:  Int J Mol Sci       Date:  2019-12-23       Impact factor: 5.923

3.  Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells.

Authors:  Monika Hudáčová; Slávka Hamuľaková; Eva Konkoľová; Rastislav Jendželovský; Jana Vargová; Juraj Ševc; Peter Fedoročko; Ondrej Soukup; Jana Janočková; Veronika Ihnatova; Tomáš Kučera; Petr Bzonek; Nikola Novakova; Daniel Jun; Lucie Junova; Jan Korábečný; Kamil Kuča; Mária Kožurková
Journal:  Int J Mol Sci       Date:  2021-04-07       Impact factor: 5.923

Review 4.  Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis.

Authors:  Saad Alghamdi; Shaheed Ur Rehman; Nashwa Talaat Shesha; Hani Faidah; Muhammad Khurram; Sabi Ur Rehman
Journal:  Molecules       Date:  2020-12-02       Impact factor: 4.411

5.  A cross-talk between integrin β4 and epidermal growth factor receptor induces gefitinib chemoresistance to gastric cancer.

Authors:  Jia Huafeng; Zhang Deqing; Ding Yong; Zhang Yulian; Hu Ailing
Journal:  Cancer Cell Int       Date:  2018-04-02       Impact factor: 5.722

6.  7-Isopenthenyloxycoumarin, Arctigenin, and Hesperidin Modify Myeloid Cell Leukemia Type-1 (Mcl-1) Gene Expression by Hormesis in K562 Cell Line.

Authors:  Zahra Kafi; Hamid Cheshomi; Omid Gholami
Journal:  Dose Response       Date:  2018-09-11       Impact factor: 2.658

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.